Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1843 (LINC01843) is a human long noncoding RNA gene located at chromosome 5q31, affiliated with the lncRNA class and characterized by its lack of protein-coding potential. Clinical studies have recognized LINC01843 as a methylation-related lncRNA associated with disease prognosis and molecular risk signatures in lung adenocarcinoma. Pathway analysis indicates enrichment in cancer-related mechanisms including epithelial-mesenchymal transition (EMT), hypoxia, stemness, and cell proliferation for the lncRNA cohort including LINC01843. There are currently no established drugs or direct pharmacological modulators for this molecule, and specific functional mechanisms and molecular interactors remain to be defined through experimental research. The gene is listed in major databases such as GeneCards, HGNC, and EBI GWAS, supporting its nomenclature as LINC01843.
Null (no drugs directly targeting LINC01843; inferred mechanisms may involve modulation of cell proliferation or methylation status)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1843 (LINC01843).